Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery… https://t.co/AzEb3ERy5f
    about 5 hours ago
  • New post on Science and Enterprise: AI Drug Discovery Company Acquired in $270M Deal https://t.co/GhPSuGMAHO #Science #Business
    about 5 hours ago
  • Drug maker Eli Lilly and Co. asked the Food and Drug Administration to revoke its authorization for bamlanivimab al… https://t.co/xtrdcKMDgx
    about 11 hours ago
  • New post on Science and Enterprise: Lilly Asks FDA to Revoke Covid-19 Therapy Clearance https://t.co/FNA6Qlklwy #Science #Business
    about 11 hours ago
  • Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in firs… https://t.co/AMeVYLYh30
    about 1 day ago

Please share Science & Enterprise

AAAS Pres: Science Drives Innovation, Economic Growth

Phillip Sharp

Phillip Sharp (A. Kotok)

13 February 2014. Phillip Sharp, professor of molecular biology at MIT and president of American Association for Advancement of Science (AAAS), underscored the tight connection between scientific advancement, entrepreneurship, and economic growth, in the opening plenary session of the AAAS annual conference in Chicago.

Sharp described the way scientific discovery feeds the economic engines of a society, with entrepreneurship serving as the link between scientific discovery and economic growth. He cited MIT as an example where one-third of MIT alumni started companies. In addition, MIT graduates are becoming entrepreneurs younger, with the average age of start-up founders falling to 28 in the 1990s, from 40 or older in the 1950s.

In and around Cambridge, Massachusetts, said Sharp, science-based start-ups are locating across the street from the university’s Kendall Square campus, to take advantage of graduates learning the latest advances. In addition, venture capital companies are also locating in the neighborhood. He said similar clusters of science-generated economic activity are happening in California, Ohio, and other locations in the U.S.

Sharp outlined two waves of innovation in the life sciences, beginning with discovery of DNA’s molecular structure by James Watson and Francis Crick in the 1950s, followed by the sequencing of the human genome in the 1990s. He said a third wave of innovation is developing with convergence of life sciences at the molecular level with engineering, the physical sciences, and mathematics.

Sharp’s research focuses on the molecular biology of gene expression related to cancer, and he shares the 1993 Nobel prize for physiology and medicine. Sharp is also co-founder of two biotechnology companies, Biogen (now Biogen Idec) and Alnylam Pharmaceuticals.

Read more:

*     *     *

 

Comments are closed.